SeaStar Medical Holding Corporation (SeaStar Medical) has filed an amendment to Form S-3 with the Securities and Exchange Commission (SEC) on August 16, 2024. The amendment pertains to the registration statement under the Securities Act of 1933 for the offering of up to 1,014,219 shares of common stock by selling securityholders. These shares are related to the exercise of certain warrants issued by SeaStar Medical. The company will not receive proceeds from the sale of shares by the selling securityholders but will receive the exercise price of the warrants unless exercised on a cashless basis. The selling securityholders may sell the shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The company has agreed to bear the costs associated with the registration of the shares, which are estimated to be $45,750. The registration allows the selling securityholders to sell their shares from time to time after the date of the prospectus, and the offering will be subject to various conditions including SEC rules and regulations.

SeaStar Medical Holding Corporation (SeaStar Medical) has filed an amendment to Form S-3 with the Securities and Exchange Commission (SEC) on August 16, 2024. The amendment pertains to the registration statement under the Securities Act of 1933 for the offering of up to 1,014,219 shares of common stock by selling securityholders. These shares are related to the exercise of certain warrants issued by SeaStar Medical. The company will not receive proceeds from the sale of shares by the selling securityholders but will receive the exercise price of the warrants unless exercised on a cashless basis. The selling securityholders may sell the shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The company has agreed to bear the costs associated with the registration of the shares, which are estimated to be $45,750. The registration allows the selling securityholders to sell their shares from time to time after the date of the prospectus, and the offering will be subject to various conditions including SEC rules and regulations.